Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin for OAB during Prostate Radiotherapy
NCT02805452Phase 3Terminated
- Sponsor
- Centre Eugène Marquis
- Start
- Jul 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in overactive bladder (OAB) comparing Solifenacin Succinate with Placebo (2 arms). Primary endpoint: Score of Urinary Symptom Profile (USP) questionnaire at 6 weeks. Started Jul 2016; status: terminated.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02805452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805452.